Altrius Capital Management’s Bayer BAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-981,292
Closed -$6.91M – 90
2024
Q2
$6.91M Buy
981,292
+45,386
+5% +$320K 1.82% 23
2024
Q1
$7.17M Buy
935,906
+231,912
+33% +$1.78M 1.81% 21
2023
Q4
$6.5M Buy
703,994
+245,258
+53% +$2.26M 1.81% 18
2023
Q3
$5.5M Buy
458,736
+21,942
+5% +$263K 1.63% 25
2023
Q2
$6.04M Buy
436,794
+61
+0% +$843 1.79% 22
2023
Q1
$6.96M Buy
436,733
+6,780
+2% +$108K 2.13% 8
2022
Q4
$5.53M Buy
429,953
+11,671
+3% +$150K 1.73% 20
2022
Q3
$4.84M Buy
418,282
+115,294
+38% +$1.33M 1.84% 18
2022
Q2
$4.5M Buy
+302,988
New +$4.5M 1.46% 21

Other funds holding BAY

Altrius Capital Management's BAY Position: Q3 2024 in Review

Altrius Capital Management sold out of Bayer (BAY) in Q3 2024, closing a stake of 981,292 shares — an estimated $6.91M sold.

Altrius Capital Management first reported a position in BAY in Q2 2022 and held it in 9 quarters. The position peaked at $7.17M in Q1 2024. 17 funds tracked by Wall St. Rank hold BAY as of Q3 2024.

  • Altrius Capital Management reported no remaining Bayer position as of Q3 2024 after selling out during the quarter.
  • Altrius Capital Management sold 981,292 Bayer shares in Q3 2024, an estimated $6.91M.
  • Altrius Capital Management first reported a position in Bayer in Q2 2022 and held it in 9 quarters.
  • Altrius Capital Management's Bayer position peaked at $7.17M in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Bayer as of Q3 2024.

Based on Altrius Capital Management's 13F filing for Q3 2024, filed 6 Nov 2024.